Welcome to Mediso

Please select your region:

North America
Europe
Rest of the World

Please select your language:

Go

AnyScan® TRIO SPECT/CT IQMAX*

Diagnostic and Theranostic Image Quality at MAXimum Level

Discover excellent image quality with the AnyScan® TRIO SPECT/CT IQMAX* featuring novel multi-pinhole collimator technology. Improve your diagnostic confidence with outstanding resolution and 360° PET-like imaging. The unique system designed with the uncompromised commitment to the best SPECT resolution.

*IQMAX is the configuration name of MAX-123/9.5 detector

Features & Benefits

Outstanding Diagnostic Image Quality

  • Detector intrinsic resolution of 2.5 mm (FWHM) provided by high-density sensor arrangement (123 PMTs per detector head)
  • Unique multi-pinhole collimator technology provides superior, PET-like image quality with optimal use of the entire detector surface
  • Triple-NaI-Detector: patient surrounded completely in 360° with three large surface detectors (up to 5x larger than 12-detector CZT systems)
  • Superior PET-like image quality became possible with the advanced Tera-Tomo™ 3D SPECT-Q image reconstruction and the unique multi-pinhole collimator technology featuring optimal use of the entire detector surface.

From General Purpose to Organ Focus Imaging

  • The IQMAX* is a versatile SPECT/CT system offering five imaging modes using Transformable™ Gantry and simple collimator exchange procedures
  • Total-Body mode unveils fast quantitative total-body SPECT/CT by all three detectors surrounding the patient
  • Brain focus imaging is possible with the dedicated MPH-Brain collimator for superior image quality DAT SPECT and Brain Perfusion SPECT
  • Cardiac focus imaging with the MPH-Cardiac collimator delivers extreme tomographic sensitivity enabling fast myocardial perfusion or amyloid scans and even dynamic SPECT acquisition
  • Dual detector modes provide real planar and SPECT imaging options

MAXimized Image Quality and Quantitative Accuracy

  • Our signature parallel-hole collimators are available for low-, medium-, and high energies.  
  • Novel multi-pinhole technology provides focused imaging for brain and cardiac applications with PET-like image quality and unveils dynamic SPECT applications.  
  • Tera-Tomo™ 3D SPECT-Q is the ultimate quantitative image reconstruction solution, featuring Monte Carlo based physical modelling of particle-level gamma photon interactions running on high-performance GPUs. 
  • List-mode acquisition is possible for retrospective image reconstructions and protocol optimization 

Triple-Performance CT

  • High power CT with up to 440 mA in diagnostic mode, 0.5 sec rotation speed, 0.625 mm resolution while offering on-the-fly dose modulation.  
  • 16 slice diagnostic CT with 32-slice reconstruction offering three performance levels: 

Standard Low Dose protocols for diagnostic CT applications 

Ultra-Low Dose CT with sub-mSv effective dose for attenuation correction and localization 

AI-Powered Synthetic CT (SyCT)** with zero effective CT dose for quantitative SPECT attenuation correction and anatomical localization in 99mTc bone imaging    

  • Iterative Image Reconstruction with Tera-Tomo™ 3D CT and advanced corrections for Motion- and Metal Artefact Reduction.  
  • Further improvement is possible with AI-based CT image quality enhancement solution. 

**For research purpose only

SyCT**– the AI-Powered Synthetic CT

Experience the innovation of zero-dose CT imaging for quantitative SPECT analysis with our AI-Powered Synthetic CT (SyCT) solution:

  • Free from the effective dose of traditional CT scans
  • Accurate SPECT attenuation correction for absolute quantification
  • Free from artifacts associated with conventional CT imaging
  • No motion and registration mismatches between SPECT and CT
  • Anatomical localization
  • Enhanced workflow efficiency: no need for dual-modality imaging
  • Applicable for 99mTc bone scans, including total-body imaging

Applications

Total-Body SPECT/CT for 99mTc-PSMA-GCK01 and Therapy Monitoring

Phenotyping PSMA positivity and personalized radioligand therapy (RLT) monitoring for prostate cancer patients. Fast and quantitative Total-Body SPECT scan with 26 minutes.

  • Collimator: LEHR-HS
  • Radiotracer: 99mTc-PSMA-GCK01
  • Applied activity: 706 MBq
  • Acquisition: 5 FOV, 5 min 12 sec/FOV
Image courtesy of Professor Uwe Haberkorn and Dr. Clemens Kratochwil

Total-Body 177Lu-PSMA-617 SPECT/CT scan

Personalized radioligand therapy (RLT) monitoring for prostate cancer patients. Fast and quantitative Total-Body SPECT scan with 26 minutes.

  • Collimator: M-LEGP
  • Radiotracer: 177Lu-PSMA-617
  • Applied activity: 7400 MBq  
  • Acquisition: 5 FOV, 5 min 12 sec/FOV
Image courtesy of Professor Uwe Haberkorn and Dr. Clemens Kratochwil

Total-Body 99mTc-MDP Bone SPECT/CT

The radionuclide bone SPECT/CT scan, aiming to evaluate the distribution of active bone formation in the skeleton related to malignant and benign diseases. Quantitative 99mTc-MDP SPECT/CT scan with 10 minutes acquisition.

  • Collimator: LEHR-HS
  • Radiotracer: 99mTc-MDP
  • Applied activity: 555 MBq
  • Acquisition: 5 FOV, 2 min/FOV SPECT/CT

Brain Focus SPECT of 123I-Ioflupane DATScan

DATScan study showing symmetrical elevated 123I-Ioflupane uptake that confirmed this patient do not have Parkinson's Syndrome.

  • Collimator: MPH-Brain
  • Radiotracer: 123I-Ioflupane
  • Applied activity: 185 MBq
  • Acquisition:

72 view, 35 sec frame time resulting in 15 min SPECT

Cardiac Focus SPECT with 99mTc-sestamibi

Myocardial perfusion SPECT imaging with the focused collimator of MPH-Cardiac on the Triple-NaI-detector provides excellent image quality and shortened acquisition time for a 62 years old male patient.

  • Collimator: MPH-Cardiac
  • Radiotracer: 99mTc-sestamibi
  • Applied activity: 359 MBq
  • Acquisition:

4 min with MPH-Cardiac collimator compared to 16 min of conventional dual-detector LEHR

Publications

Images

How can we help you?

Don't hesitate to contact us for technical information or to find out more about our products and services.

Get in touch